Tricida, Inc. has reached its limit for free report views

Work for Tricida, Inc.? Upgrade Your Profile and unlock all your annual reports.

Upgrade Profile

Tricida, Inc.

Ticker TCDA

Exchange NASDAQ More
Industry Drug Manufacturers - Major More
Sector Healthcare More

51-200 Employees
Based in South San Francisco, California

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Tricida is currently conducting the VALOR-CKD clinical trial to evaluate the efficacy and safety of veverimer in delaying CKD progression…More

Visit website

REPORT RATINGS

4.8 / 5.0 (212)

Tricida, Inc. reports have an aggregate usefulness score of 4.8 based on 212 reviews.

Tricida, Inc.